DeepMind Technologies Limited, also known as Google DeepMind, is a privately owned British-American artificial intelligence research laboratory and subsidiary of Google, headquartered in the UK. Founded in 2010, the company employs approximately 2,020 individuals, functioning primarily to offer research services.
On March 13, 2026, Google DeepMind's AlphaFold technology featured in multiple advancements. AlphaFold2’s accuracy significantly impacted protein science, revolutionizing structural and functional annotation by enabling a "predict-understand-create" cycle. This deep learning method, integrated with AI-driven cryo-EM, facilitates *de novo* complex structure modeling and allows generative models to design novel proteins with specific structures and functions. Concurrently, tech entrepreneur Steven Scholz reportedly used AI tools, including AlphaFold, to design a custom mRNA cancer vaccine for his dying dog, achieving a 50 percent tumor shrinkage through this personalized medicine approach.
Similar Companies
Subscribe for full access to Google DeepMind's profile
Google DeepMind offers 3 products in the enterprise tech and media tech industries. Google DeepMind's product portfolio comprises of generative AI and sports tech.
Subscribe for full access to Google DeepMind's products in full detail
Subscribe for full access to Google DeepMind's revenue in full detail
Subscribe for full access to Google DeepMind's products in full detail 
